InCarda Therapeutics, Inc.

Pharmaceutical company · Newark, California, United States

InCarda Therapeutics, Inc. is a pharmaceutical company headquartered in Newark, California, United States. Its earliest recorded incorporation is in 2009. It has reported private securities offerings to the US SEC, most recently $28 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

InCarda Therapeutics at a glance

Typepharmaceutical company

HeadquartersNewark, California, United States

Earliest incorporation on record2009

SEC CIK1552622

What does InCarda Therapeutics do?

Private fundraising reported to the SEC

6 Form D notices; the most recent reported $28 million sold (2020).

Frequently asked questions about InCarda Therapeutics

Where is InCarda Therapeutics headquartered?

InCarda Therapeutics, Inc. is headquartered in Newark, California, United States.

What does InCarda Therapeutics do?

InCarda Therapeutics, Inc. is a pharmaceutical company.

When was InCarda Therapeutics founded?

The earliest incorporation on record for InCarda Therapeutics, Inc. is in 2009, according to public company registers.

Similar companies

Protagonist Therapeutics, IncNewark, California, United States
Rain Oncology Inc.Newark, California, United States
Rafael Holdings, Inc.Newark, New Jersey, United States
CymaBay Therapeutics, Inc.Newark, California, United States
Symbiomix Therapeutics, LLCNewark, New Jersey, United States
Inergetics IncNewark, New Jersey, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences